Aberrant over-expression of a forkhead family member, FOXO1A, in a brain tumor cell line

Peter B. Dallas(Fremantle Hospital), Ursula R. Kees(The University of Western Australia)
BMC Cancer
April 19, 2007
10.1186/1471-2407-7-67
Cited by 2

Related Papers

Comparative drug screening in NUT midline carcinoma
|British Journal of Cancer|2014|52
Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
|Leukemia|2016|29
Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children’s Hospital
|BMC Cancer|2021|11